Skip to contentClarengateINTELLIGENCE
Companies/11417841

Magellan Life Sciences Limited

Other research and experimental development on natural sciences and engineering · London

ActiveUnited KingdomIncorporated 2018Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-12-31

IXBRL · 100 source facts · 22 selected values

Validation findings
XBRL valid
Reporting period
2025-01-01 to 2025-12-31
Extraction status
complete
Numeric facts
60
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod224_2604_11417841_20251231
Source archive
Accounts_Monthly_Data-April2026.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-12-31

IXBRL · 117 source facts · 20 selected values

Validation findings
XBRL valid
Reporting period
2024-01-01 to 2024-12-31
Extraction status
complete
Numeric facts
56
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_2509_11417841_20241231
Source archive
Accounts_Monthly_Data-September2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2023-12-31

IXBRL · 120 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2023-01-01 to 2023-12-31
Extraction status
Legacy / not assessed
Numeric facts
56
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_2476_11417841_20231231
Source archive
Accounts_Monthly_Data-September2024.zip

Accounts to 2021-12-31

IXBRL · 71 source facts · 17 selected values

Not assessed
legacy record
Reporting period
2021-01-01 to 2021-12-31
Extraction status
Legacy / not assessed
Numeric facts
34
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0102_11417841_20211231
Source archive
Accounts_Monthly_Data-February2022.zip

Accounts to 2020-12-31

IXBRL · 58 source facts · 14 selected values

Not assessed
legacy record
Reporting period
2020-01-01 to 2020-12-31
Extraction status
Legacy / not assessed
Numeric facts
21
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0094_11417841_20201231
Source archive
Accounts_Monthly_Data-September2021.zip

Accounts to 2019-12-31

IXBRL · 37 source facts · 6 selected values

Not assessed
legacy record
Reporting period
2019-01-01 to 2019-12-31
Extraction status
Legacy / not assessed
Numeric facts
8
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0087_11417841_20191231
Source archive
Accounts_Monthly_Data-February2021.zip

Registered details

11417841
Status
Active
Type
Private Limited Company
Incorporated
2018-06-15
Jurisdiction
—
Registered office
CANNON PLACE, 78 CANNON STREET, LONDON, UNITED KINGDOM, EC4N 6AF, ENGLAND

Classification

1 SIC codes
72190

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

3 matched grants
BRAZZEIN - Development and Commercialization of Novel Low Calorie Food & Beverage ProductsLead
Innovate UK · Collaborative R&D · 2025-04-01 – 2026-09-30
£227,459
awarded
A novel approach to scaling up production of Brazzein - a natural, non-caloric protein sweetener and sugar alternative that can address UK and global sugar-related obesity epidemics and health challengesLead
Innovate UK · Collaborative R&D · 2023-09-01 – 2025-02-28 · with 1 other participant
£182,549
awarded
Magellan Life Sciences Limitedlead£182,549
BRAZZX - Developing a scalable and predictable fermentation process for Brazzein, a new, non-caloric protein sweetenerLead
Innovate UK · Collaborative R&D · 2022-03-01 – 2023-08-31
£257,764
awarded